Literature DB >> 212091

Studies with primaquine in vitro: superoxide radical formation and oxidation of haemoglobin.

M Summerfield, G R Tudhope.   

Abstract

1. The production of superoxide radicals from primaquine diphosphate in aqueous solution has been demonstrated, using as indicator the reduction of cytochrome C with inhibition of the reaction by superoxide dismutase. 2. Primaquine-mediated oxidation of haemoglobin to methaemoglobin was reduced by the addition of catalase and increased by superoxide dismutase. Mannitol, a hydroxyl radical scavenger, abolished the increase in methaemoglobin observed in the presence of superoxide dismutase. EDTA reduced the oxidation of haemoglobin with and without superoxide dismutase. 3. Although the oxidation of haemoglobin in the presence of primaquine includes the effects of hydrogen peroxide, superoxide and hydroxyl radicals and metal ions, the results indicate that hydrogen peroxide, rather than the superoxide radical, is the main oxidizing species. The increase in haemoglobin oxidation occurring with superoxide dismutase may result from the augmented rate of hydrogen peroxide formation from superoxide radicals.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 212091      PMCID: PMC1429464          DOI: 10.1111/j.1365-2125.1978.tb00858.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

1.  GENERATION OF HYDROGEN PEROXIDE IN ERYTHROCYTES BY HEMOLYTIC AGENTS.

Authors:  G COHEN; P HOCHSTEIN
Journal:  Biochemistry       Date:  1964-07       Impact factor: 3.162

2.  GLUTATHIONE PEROXIDASE: THE PRIMARY AGENT FOR THE ELIMINATION OF HYDROGEN PEROXIDE IN ERYTHROCYTES.

Authors:  G COHEN; P HOCHSTEIN
Journal:  Biochemistry       Date:  1963 Nov-Dec       Impact factor: 3.162

3.  IN VIVO GENERATION OF H2O2 IN MOUSE ERYTHROCYTES BY HEMOLYTIC AGENTS.

Authors:  G COHEN; P HOCHSTEIN
Journal:  J Pharmacol Exp Ther       Date:  1965-01       Impact factor: 4.030

4.  The hemolytic effect of primaquine and related compounds: a review.

Authors:  E BEUTLER
Journal:  Blood       Date:  1959-02       Impact factor: 22.113

5.  Hemoglobin catabolism. I. Glutathione peroxidase, an erythrocyte enzyme which protects hemoglobin from oxidative breakdown.

Authors:  G C MILLS
Journal:  J Biol Chem       Date:  1957-11       Impact factor: 5.157

6.  Inhibition by superoxide dismutase of methemoglobin formation from oxyhemoglobin.

Authors:  R E Lynch; R Lee; G E Cartwright
Journal:  J Biol Chem       Date:  1976-02-25       Impact factor: 5.157

7.  The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents.

Authors:  G Cohen; R E Heikkila
Journal:  J Biol Chem       Date:  1974-04-25       Impact factor: 5.157

Review 8.  Superoxide dismutases.

Authors:  I Fridovich
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1974

9.  Effects of drugs and drug metabolites on erythrocytes from normal and glucose-6-phosphate dehydrogenase-deficient individuals.

Authors:  I M Fraser; E S Vesell
Journal:  Ann N Y Acad Sci       Date:  1968-07-31       Impact factor: 5.691

Review 10.  The biochemical production of ferrihemoglobin-forming derivatives from aromatic amines, and mechanisms of ferrihemoglobin formation.

Authors:  M Kiese
Journal:  Pharmacol Rev       Date:  1966-09       Impact factor: 25.468

View more
  2 in total

Review 1.  8-Aminoquinoline Therapy for Latent Malaria.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2019-07-31       Impact factor: 26.132

2.  Long-range structural defects by pathogenic mutations in most severe glucose-6-phosphate dehydrogenase deficiency.

Authors:  Naoki Horikoshi; Sunhee Hwang; Cornelius Gati; Tsutomu Matsui; Carlos Castillo-Orellana; Andrew G Raub; Adriana A Garcia; Fatemeh Jabbarpour; Alexander Batyuk; Joshua Broweleit; Xinyu Xiang; Andrew Chiang; Rachel Broweleit; Esteban Vöhringer-Martinez; Daria Mochly-Rosen; Soichi Wakatsuki
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-26       Impact factor: 12.779

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.